Literature DB >> 23893962

Use of CD157 in FLAER-based assays for high-sensitivity PNH granulocyte and PNH monocyte detection.

D R Sutherland1, E Acton, M Keeney, B H Davis, A Illingworth.   

Abstract

Background: Recent Flow Cytometric guidelines to detect Paroxysmal Nocturnal Hemoglobinuria (PNH) in white blood cells recommend using FLAER-based assays to detect granulocytes and monocytes lacking expression of GPI-linked structures. However national proficiency testing results continue to suggest a need for improved testing algorithms, including the need to optimize diagnostic analytes in PNH.
Methods: CD157 is another GPI-linked structure expressed on both granulocytes and monocytes and here we assess its ability to replace CD24 and CD14 in predicate 4-color granulocyte and monocyte assays respectively. We also assess a single tube, 5-color combination of FLAER, CD157, CD64, CD15 and CD45 to simultaneously detect PNH clones in granulocyte and monocyte lineages.
Results: Delineation of PNH from normal phenotypes with 4- or 5-color CD157-based assays compared favorably with 4-color predicate methods and PNH clone size data were similar and highly correlated (R2 >0.99) with predicate values over a range (0.06% - 99.8%) of samples. Both CD157-based assays exhibited similar high levels of sensitivity and low background levels in normal samples.
Conclusion: While CD157-based 4- and 5-color assays generated closely similar results to the predicate assays on a range of PNH and normal samples, the 5-color assay has significant advantages. Only a single 5-color WBC reagent cocktail is required to detect both PNH granulocytes and monocytes. Additionally, sample preparation and analysis time is reduced yielding significant efficiencies in technical resources and reagent costs. All 4- and 5-color reagent sets stained stabilized whole blood PNH preparations, used in external quality assurance programs. © 2013 Clinical Cytometry Society.
Copyright © 2013 Clinical Cytometry Society.

Entities:  

Keywords:  CD157; high sensitivity 5-color flow; paroxysmal nocturnal hemoglobinuria

Year:  2013        PMID: 23893962     DOI: 10.1002/cytob.21111

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  2 in total

Review 1.  Diagnosis of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances.

Authors:  Prabhu Manivannan; Ankur Ahuja; Hara Prasad Pati
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-08       Impact factor: 0.900

2.  Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria.

Authors:  Carmelo Gurnari; Amy C Graham; Alexey Efanov; Simona Pagliuca; Jibran Durrani; Hassan Awada; Bhumika J Patel; Alan E Lichtin; Valeria Visconte; Mikkael A Sekeres; Jaroslaw P Maciejewski
Journal:  Blood Cells Mol Dis       Date:  2020-12-08       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.